pyrrolidonecarboxylic acid has been researched along with T-Cell Lymphoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kameda, G; Mayatepek, E; Schwahn, B; Wessalowski, R | 1 |
| Coppi, G; Delfino, D; Maggioni, A; Migliorati, G; Nicoletti, I; Riccardi, C | 1 |
2 other study(ies) available for pyrrolidonecarboxylic acid and T-Cell Lymphoma
| Article | Year |
|---|---|
Severe hyperhomocysteinaemia and 5-oxoprolinuria secondary to antiproliferative and antimicrobial drug treatment.
Topics: Acidosis; Anions; Anti-Infective Agents; Antineoplastic Agents; Child; Female; Glutathione; Homocysteine; Humans; Hyperhomocysteinemia; Lymphoma, T-Cell; Phenytoin; Polymorphism, Genetic; Pyrrolidonecarboxylic Acid; Time Factors | 2005 |
[Pidotimod causes apoptotic cell death and inhibits the proliferative activity of YAC-1 tumor cells in vitro].
Topics: Adjuvants, Immunologic; Animals; Antineoplastic Agents; Apoptosis; Biological Transport; Calcium; Cell Division; DNA, Neoplasm; Drug Screening Assays, Antitumor; G2 Phase; Lymphoma, T-Cell; Mice; Mice, Inbred A; Mitosis; Neoplasm Proteins; Neoplastic Stem Cells; Phosphoproteins; Phosphorylation; Protein Processing, Post-Translational; Pyrrolidonecarboxylic Acid; T-Lymphocytes; Thiazoles; Thiazolidines; Tumor Cells, Cultured | 1993 |